Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02909907 · ClinicalTrials.gov registry record · NA
Comparison of Botulinum Toxin Injections in Forearm FLexor Plus EXtensor Muscles vs. Flexor Muscles Alone for Treatment of Essential Hand Tremor(FLEX-D ET)
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02909907 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 21 participants.
The verdict
NCT02909907, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
To compare the efficacy of botulinum toxin (BoNT) injections in forearm flexors plus extensor muscles versus flexors alone for the treatment of essential hand tremor (ET).
Interventions
- OTHER Placebo
- DRUG Botulinum toxin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02909907
The ClinicalTrials.gov registry entry for NCT02909907 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02909907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02909907 about?
NCT02909907 is a clinical study titled "Comparison of Botulinum Toxin Injections in Forearm FLexor Plus EXtensor Muscles vs. Flexor Muscles Alone for Treatment of Essential Hand Tremor(FLEX-D ET)". To compare the efficacy of botulinum toxin (BoNT) injections in forearm flexors plus extensor muscles versus flexors alone for the treatment of essential hand tremor (ET).
What is the current status of trial NCT02909907?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2016-08. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT02909907?
The interventions under investigation include: Placebo (OTHER), Botulinum toxin (DRUG).
Who is sponsoring clinical trial NCT02909907?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.